SCHEMBL7039348

SCHEMBL7039348

COc1ccc(C(=O)CBr)cc1NS(C)(=O)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
KMT2A Q03164 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
MEN1 O00255 3/20 0.50
KDM4E B2RXH2 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CYP2C9 P11712 1/20 0.48
GSK3B P49841 1/20 0.46
MAPT P10636 3/20 0.46
LMNA P02545 1/20 0.46
ADRB3 P13945 3/20 0.44
MAPK1 P28482 1/20 0.43
BRD4 O60885 2/20 0.43
ACLY P53396 1/20 0.43
PDE4B Q07343 1/20 0.42
PDE4D Q08499 1/20 0.42
PTPN1 P18031 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4857075 0.86 SMN1; SMN2 (0.48) ALDH1A1KMT2ASMN1; SMN2MEN1KDM4E
SCHEMBL11918926 0.83 THRA (0.44) ALDH1A1SMN1; SMN2KDM4EHSD17B10LMNA
SCHEMBL10895603 0.83 SMN1; SMN2 (0.41) ALDH1A1KMT2ASMN1; SMN2MEN1KDM4E
SCHEMBL5071184 0.82 SMN1; SMN2 (0.70) ALDH1A1KMT2ASMN1; SMN2MEN1KDM4E
SCHEMBL5494824 0.82 ACLY (0.58) ALDH1A1KMT2ASMN1; SMN2MEN1KDM4E
SCHEMBL11282353 0.82 KMT2A (0.47) ALDH1A1KMT2ASMN1; SMN2MEN1KDM4E
SCHEMBL1221632 0.81 CYP19A1 (0.50) ALDH1A1KMT2ASMN1; SMN2MEN1ADRB3
SCHEMBL7107204 0.81 ADRB3 (0.47) ALDH1A1KMT2ASMN1; SMN2KDM4EHSD17B10
SCHEMBL2546108 0.81 ADRB3 (0.64) SMN1; SMN2KDM4EHSD17B10GSK3BADRB3
SCHEMBL4852193 0.81 ALDH1A1 (0.48) ALDH1A1KMT2ASMN1; SMN2MEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 EP disclosed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 EP disclosed